Join us for a KOL Webinar, featuring David V. Sheehan MD, MBA, FACPsych, DLFAPA (University of South Florida College of Medicine) who will discuss the unmet medical needs in suicide and depression and provide insight into the existing treatment landscape. The discussion, moderated by Mike Moyer (LifeSci Advisors), will highlight Seelos Therapeutics’ asset SLS-002 (intranasal racemic ketamine), currently in a…
Read more
To register for the Seelos Therapeutics, Inc. webcast from the Jefferies Healthcare Conference on 6/8/2023 beginning at 9:00 AM (ET), please enter your information in the form below. https://wsw.com/webcast/jeff281/register.aspx?conf=jeff281&page=seel&url=https://wsw.com/webcast/jeff281/seel/1843270
